(VIANEWS) – Another day of trading has ended and here’s today’s list of stocks that have had significant trading activity in the US session.
The three biggest winners today are Methes Energies International Ltd, Oxbridge Re Holdings Limited, and Mannatech.
| Rank | Financial Asset | Price | Change | Updated (EST) |
|---|---|---|---|---|
| 1 | Methes Energies International Ltd (MEIL) | 0.03 | 55.41% | 2023-08-07 01:13:07 |
| 2 | Oxbridge Re Holdings Limited (OXBR) | 1.58 | 19.7% | 2023-08-07 15:47:08 |
| 3 | Mannatech (MTEX) | 13.80 | 19.48% | 2023-08-07 05:14:08 |
| 4 | National American University Holdings (NAUH) | 0.07 | 18.58% | 2023-08-07 07:08:08 |
| 5 | Freshpet (FRPT) | 81.75 | 10.86% | 2023-08-07 13:10:07 |
| 6 | Mercer International (MERC) | 9.18 | 9.81% | 2023-08-07 01:17:07 |
| 7 | Nano Dimension (NNDM) | 3.01 | 7.96% | 2023-08-07 13:15:17 |
| 8 | OraSure Technologies (OSUR) | 6.40 | 7.74% | 2023-08-07 15:12:07 |
| 9 | AMC (AMC) | 5.22 | 5.78% | 2023-08-07 13:17:06 |
| 10 | Liberty Media (LSXMB) | 26.86 | 5.75% | 2023-08-07 10:37:09 |
The three biggest losers today are FuboTV, ImmunoGen, and Aspen Group.
| Rank | Financial Asset | Price | Change | Updated (EST) |
|---|---|---|---|---|
| 1 | FuboTV (FUBO) | 2.59 | -18.2% | 2023-08-07 13:47:01 |
| 2 | ImmunoGen (IMGN) | 14.73 | -13.63% | 2023-08-07 13:10:49 |
| 3 | Aspen Group (ASPU) | 0.16 | -8.82% | 2023-08-07 13:14:02 |
| 4 | BeiGene (BGNE) | 185.93 | -8.08% | 2023-08-07 13:14:04 |
| 5 | Redfin (RDFN) | 10.00 | -7.81% | 2023-08-07 13:15:35 |
| 6 | Neonode (NEON) | 2.14 | -7.76% | 2023-08-07 07:23:09 |
| 7 | NN (NNBR) | 2.75 | -7.72% | 2023-08-07 08:23:09 |
| 8 | SmileDirectClub (SDC) | 0.84 | -7.62% | 2023-08-07 10:45:34 |
| 9 | Nikola (NKLA) | 2.31 | -7.61% | 2023-08-07 13:15:15 |
| 10 | FibroGen (FGEN) | 1.77 | -7.59% | 2023-08-07 13:09:44 |
Winners today
1. Methes Energies International Ltd (MEIL) – 55.41%
Methes Energies International Ltd., a renewable energy company, produces and sells biodiesel fuel and biodiesel processing equipment in the United States and Canada. It offers Denami biodiesel processors. The company also produces glycerin and offer services related to the production of biodiesel, as well as purchases and sells feedstock. It sells its products and services to a network of biodiesel fuel producers. The company was founded in 2004 and is headquartered in Las Vegas, Nevada.
NASDAQ ended the session with Methes Energies International Ltd jumping 55.41% to $0.03 on Monday while NASDAQ rose 0.61% to $13,994.40.
Earnings Per Share
As for profitability, Methes Energies International Ltd has a trailing twelve months EPS of $-0.35.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -61.54%.
More news about Methes Energies International Ltd.
2. Oxbridge Re Holdings Limited (OXBR) – 19.7%
Oxbridge Re Holdings Limited, together with its subsidiaries, provides specialty property and casualty reinsurance solutions. It underwrites reinsurance contracts primarily for property and casualty insurance companies in the Gulf Coast region of the United States. The company distributes its products and solutions through reinsurance brokers. Oxbridge Re Holdings Limited was incorporated in 2013 and is headquartered in George Town, the Cayman Islands.
NASDAQ ended the session with Oxbridge Re Holdings Limited rising 19.7% to $1.58 on Monday, after five successive sessions in a row of losses. NASDAQ jumped 0.61% to $13,994.40, after four successive sessions in a row of losses, on what was a somewhat up trend exchanging session today.
Earnings Per Share
As for profitability, Oxbridge Re Holdings Limited has a trailing twelve months EPS of $-0.22.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -8%.
Yearly Top and Bottom Value
Oxbridge Re Holdings Limited’s stock is valued at $1.58 at 17:32 EST, way below its 52-week high of $3.43 and way higher than its 52-week low of $1.07.
Volume
Today’s last reported volume for Oxbridge Re Holdings Limited is 103423 which is 525.06% above its average volume of 16546.
Moving Average
Oxbridge Re Holdings Limited’s value is under its 50-day moving average of $1.65 and under its 200-day moving average of $1.75.
More news about Oxbridge Re Holdings Limited.
3. Mannatech (MTEX) – 19.48%
Mannatech, Incorporated operates as a health and wellness company worldwide. It develops, markets, and sells nutritional supplements; topical and skin care, and anti-aging products; and weight-management products. The company primarily sells its products directly, as well as through network marketing channels and a website. Mannatech, Incorporated was founded in 1993 and is headquartered in Flower Mound, Texas.
NASDAQ ended the session with Mannatech rising 19.48% to $13.80 on Monday, after three sequential sessions in a row of gains. NASDAQ jumped 0.61% to $13,994.40, after four sequential sessions in a row of losses, on what was a somewhat positive trend exchanging session today.
Earnings Per Share
As for profitability, Mannatech has a trailing twelve months EPS of $-2.11.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -21.39%.
Volume
Today’s last reported volume for Mannatech is 17140 which is 1520.04% above its average volume of 1058.
More news about Mannatech.
4. National American University Holdings (NAUH) – 18.58%
National American University Holdings, Inc. owns and operates National American University (NAU) that provides professional and technical postsecondary education primarily for working adults and other non-traditional students in the United States. It operates in two segments, NAU and Other. The company offers diploma, associate, baccalaureate, master's, and doctoral degree programs in business-related disciplines, such as accounting, management, business administration, and information technology; healthcare-related disciplines, including occupational therapy, medical assisting, nursing, surgical technology, and healthcare information and management; legal-related disciplines comprising paralegal, criminal justice, and professional legal studies; and higher education. As of July 31, 2019, it operated five 33 educational sites in Colorado, Indiana, Kansas, South Dakota, and Texas; and distance learning service centers and administration offices in Rapid City, South Dakota, as well as through the Internet. The company also engages in the real estate business, which rents apartment units; and develops and sells condominium units in the Fairway Hills Planned Residential Development area of Rapid City, South Dakota. National American University Holdings, Inc. was founded in 1941 and is headquartered in Rapid City, South Dakota.
NASDAQ ended the session with National American University Holdings rising 18.58% to $0.07 on Monday while NASDAQ jumped 0.61% to $13,994.40.
Earnings Per Share
As for profitability, National American University Holdings has a trailing twelve months EPS of $0.17.
PE Ratio
National American University Holdings has a trailing twelve months price to earnings ratio of 0.39. Meaning, the purchaser of the share is investing $0.39 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -183.64%.
Moving Average
National American University Holdings’s value is above its 50-day moving average of $0.07 and way under its 200-day moving average of $0.09.
More news about National American University Holdings.
5. Freshpet (FRPT) – 10.86%
Freshpet, Inc. manufactures and markets natural fresh meals and treats for dogs and cats in the United States, Canada, and Europe. The company sells its products under the Freshpet brand; and Dognation and Dog Joy labels through various classes of retail, including grocery, mass, club, pet specialty, and natural, as well as online. Freshpet, Inc. was incorporated in 2004 and is headquartered in Secaucus, New Jersey.
NASDAQ ended the session with Freshpet rising 10.86% to $81.75 on Monday, following the last session’s upward trend. NASDAQ rose 0.61% to $13,994.40, after four consecutive sessions in a row of losses, on what was a somewhat bullish trend trading session today.
Freshpet (frpt) reports Q2 loss, misses revenue estimatesWhile Freshpet has outperformed the market so far this year, the question that comes to investors’ minds is: what’s next for the stock?
Earnings Per Share
As for profitability, Freshpet has a trailing twelve months EPS of $-1.46.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -8.06%.
Sales Growth
Freshpet’s sales growth is 26.8% for the ongoing quarter and 27.1% for the next.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter and the next is 4.4% and 59%, respectively.
Volume
Today’s last reported volume for Freshpet is 1491120 which is 150.32% above its average volume of 595677.
More news about Freshpet.
6. Mercer International (MERC) – 9.81%
Mercer International Inc., together with its subsidiaries, manufactures and sells northern bleached softwood kraft (NBSK) pulp in Europe, the United States, Asia, and internationally. It operates through two segments, Pulp and Wood Products. The company also generates and sells green energy produced from biomass cogeneration power plant to third party utilities. In addition, it manufactures, distributes, and sells lumber and other wood residuals. Further, the company produces NBSK pulp primarily from wood chips, pulp logs, and sawlogs; carbon neutral or green energy using carbon-neutral bio-fuels, such as black liquor and wood waste; and tall oil for use as a chemical additive and green energy source. It sells its pulp to tissue, specialty paper, and printing and writing paper, and other manufacturers; and lumber products to distributors, construction firms, secondary manufacturers, retail yards, and home centers. The company was founded in 1968 and is headquartered in Vancouver, Canada.
NASDAQ ended the session with Mercer International rising 9.81% to $9.18 on Monday while NASDAQ rose 0.61% to $13,994.40.
Earnings Per Share
As for profitability, Mercer International has a trailing twelve months EPS of $1.91.
PE Ratio
Mercer International has a trailing twelve months price to earnings ratio of 4.81. Meaning, the purchaser of the share is investing $4.81 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -5.67%.
Growth Estimates Quarters
The company’s growth estimates for the present quarter and the next is 590.9% and 450%, respectively.
Dividend Yield
As stated by Morningstar, Inc., the next dividend payment is on Jun 26, 2023, the estimated forward annual dividend rate is 0.3 and the estimated forward annual dividend yield is 3.5%.
Volume
Today’s last reported volume for Mercer International is 1940960 which is 168.05% above its average volume of 724096.
Yearly Top and Bottom Value
Mercer International’s stock is valued at $9.18 at 17:32 EST, way under its 52-week high of $17.50 and way above its 52-week low of $7.37.
More news about Mercer International.
7. Nano Dimension (NNDM) – 7.96%
Nano Dimension Ltd., together with its subsidiaries, provides additive electronics in Israel and internationally. The company offers 3D printers, comprising DragonFly IV that produces Hi-PEDs by depositing proprietary conductive and dielectric substances, as well as integrates in-situ capacitors, antennas, coils, transformers, and electromechanical components; digital light processing printers (DLP) that achieves production-grade polymer and composite parts; and admaflex that utilizes a patented DLP foil system that fabricates ceramic and metal parts. It also provides additive electronics robotics and control systems, which includes surface-mount-technology, an electronics assembly equipment for electronic components on Hi-PEDs and PCBs, catering to various manufacturing and volume requirements; and ink delivery systems controls electronics, software, and ink delivery systems for digital printing. In addition, the company offers software to provide engineers with the tools to bring precision and electrical parts from design-to-manufacturing, as well as sells various materials that are developed in-house. Nano Dimension Ltd. was incorporated in 1960 and is headquartered in Ness Ziona, Israel.
NASDAQ ended the session with Nano Dimension jumping 7.96% to $3.01 on Monday while NASDAQ jumped 0.61% to $13,994.40.
Earnings Per Share
As for profitability, Nano Dimension has a trailing twelve months EPS of $-0.67.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -13.95%.
Yearly Top and Bottom Value
Nano Dimension’s stock is valued at $3.01 at 17:32 EST, way under its 52-week high of $3.74 and way above its 52-week low of $2.06.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Nano Dimension’s stock is considered to be overbought (>=80).
More news about Nano Dimension.
8. OraSure Technologies (OSUR) – 7.74%
OraSure Technologies, Inc., together with its subsidiaries, develops, manufactures, markets, and sells oral fluid diagnostic products and specimen collection devices in the United States, Europe, and internationally. It operates in two segments, Diagnostics and Molecular Solutions. The company's principal products include InteliSwab COVID-19 rapid test, InteliSwab COVID-19 rapid test pro, InteliSwab COVID-19 rapid test rx, OraQuick Rapid HIV test, OraQuick In-Home HIV test, OraQuick HIV self-test, OraQuick HCV rapid antibody test, OraQuick Ebola rapid antigen test, OraSure oral fluid collection device used in conjunction with screening and confirmatory tests for HIV-1 antibodies; Intercept drug testing systems; immunoassay tests and reagents; and Q.E.D. saliva alcohol test. It also offers genomic products under the Oragene and ORAcollect brands; microbiome collection products; and GenoFIND genomics laboratory services. In addition, the company provides ORAcollect, RNA and OMNIgene, and RAL collection devices for use in connection with COVID-19 molecular testing; offers Colli-Pee collection device for the volumetric collection of first void urine; and manufactures and sells kits that are used to collect, stabilize, transport, and store samples of genetic material for molecular testing in the academic research and commercial applications, including ancestry, disease risk management, lifestyle, and animal testing. Further, it provides other diagnostic products, such as immunoassays and other in vitro diagnostic tests. The company markets its products to clinical laboratories, hospitals, clinics, community-based organizations and other public health organizations, distributors, government agencies, physicians' offices, and commercial and industrial entities. OraSure Technologies, Inc. was incorporated in 2000 and is headquartered in Bethlehem, Pennsylvania.
NASDAQ ended the session with OraSure Technologies rising 7.74% to $6.40 on Monday, following the last session’s upward trend. NASDAQ rose 0.61% to $13,994.40, after four successive sessions in a row of losses, on what was a somewhat up trend exchanging session today.
Earnings Per Share
As for profitability, OraSure Technologies has a trailing twelve months EPS of $0.41.
PE Ratio
OraSure Technologies has a trailing twelve months price to earnings ratio of 15.61. Meaning, the purchaser of the share is investing $15.61 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 11.65%.
Moving Average
OraSure Technologies’s value is way higher than its 50-day moving average of $4.98 and way higher than its 200-day moving average of $5.40.
Volume
Today’s last reported volume for OraSure Technologies is 1915480 which is 187.55% above its average volume of 666122.
Sales Growth
OraSure Technologies’s sales growth is negative 46.7% for the current quarter and negative 59.6% for the next.
Yearly Top and Bottom Value
OraSure Technologies’s stock is valued at $6.40 at 17:32 EST, way under its 52-week high of $7.82 and way above its 52-week low of $3.13.
More news about OraSure Technologies.
9. AMC (AMC) – 5.78%
AMC Entertainment Holdings, Inc., through its subsidiaries, engages in the theatrical exhibition business. The company owns, operates, or has interests in theatres in the United States and Europe. AMC Entertainment Holdings, Inc. was founded in 1920 and is headquartered in Leawood, Kansas.
NYSE ended the session with AMC jumping 5.78% to $5.22 on Monday while NYSE rose 0.85% to $16,208.23.
AMC entertainment (amc) to post Q2 earnings: what's in store?Our proven model doesn’t conclusively predict an earnings beat for AMC Entertainment this time around.
Earnings Per Share
As for profitability, AMC has a trailing twelve months EPS of $-0.67.
Volume
Today’s last reported volume for AMC is 22163900 which is 4.96% below its average volume of 23320800.
Moving Average
AMC’s worth is way above its 50-day moving average of $4.60 and under its 200-day moving average of $5.38.
Revenue Growth
Year-on-year quarterly revenue growth grew by 21.5%, now sitting on 4.08B for the twelve trailing months.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, AMC’s stock is considered to be oversold (<=20).
More news about AMC.
10. Liberty Media (LSXMB) – 5.75%
The Liberty SiriusXM Group, through its subsidiaries, engages in the entertainment business in the United States and Canada. It features music, sports, entertainment, comedy, talk, news, traffic, weather channels, podcast, and infotainment services through proprietary satellite radio systems, as well as streamed through applications for mobile and home devices, and other consumer electronic equipment. It also offers connected vehicle services; a suite of data services that include graphical weather, fuel prices, sports schedules and scores, and movie listings; and traffic information services, which provide information as to road closings, traffic flow and incident data to consumers with compatible in-vehicle navigation systems, and real-time weather services in vehicles, boats, and planes. In addition, the company operates a music, comedy, and podcast streaming platform. Further, it offers ad-supported radio services; Pandora Plus, a radio subscription service; and Pandora Premium, an on-demand subscription service. Additionally, the company distributes satellite radios through automakers and retailers, as well as through its website. As of December 31, 2021, it served approximately 34.0 million subscribers through Sirius XM and approximately 6.4 million subscribers through Pandora. The Liberty SiriusXM Group is based in Englewood, Colorado. The Liberty SiriusXM Group operates as a subsidiary of Liberty Media Corporation.
NASDAQ ended the session with Liberty Media jumping 5.75% to $26.86 on Monday, following the last session’s downward trend. NASDAQ jumped 0.61% to $13,994.40, after four sequential sessions in a row of losses, on what was a somewhat positive trend trading session today.
Earnings Per Share
As for profitability, Liberty Media has a trailing twelve months EPS of $3.22.
PE Ratio
Liberty Media has a trailing twelve months price to earnings ratio of 8.34. Meaning, the purchaser of the share is investing $8.34 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 11.79%.
More news about Liberty Media.
Losers Today
1. FuboTV (FUBO) – -18.2%
fuboTV Inc. operates a live TV streaming platform for live sports, news, and entertainment content in the United States and internationally. Its fuboTV platform allows customers to access content through streaming devices, as well as on SmartTVs, computers, mobile phones, and tablets. The company is headquartered in New York, New York.
NYSE ended the session with FuboTV dropping 18.2% to $2.59 on Monday while NYSE jumped 0.85% to $16,208.23.
Earnings Per Share
As for profitability, FuboTV has a trailing twelve months EPS of $-1.95.
Volume
Today’s last reported volume for FuboTV is 28933400 which is 73.09% above its average volume of 16715100.
Volatility
FuboTV’s last week, last month’s, and last quarter’s current intraday variation average was a negative 1.64%, a positive 2.09%, and a positive 6.10%.
FuboTV’s highest amplitude of average volatility was 2.27% (last week), 6.82% (last month), and 6.10% (last quarter).
More news about FuboTV.
2. ImmunoGen (IMGN) – -13.63%
ImmunoGen, Inc., a commercial-stage biotechnology company, focuses on developing and commercializing the antibody-drug conjugates (ADCs) for cancer patients. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), for the treatment of platinum-resistant ovarian cancer; and a cell-surface protein expressed in various epithelial tumors, including ovarian, endometrial, and non-small-cell lung cancers, as well as Pivekimab sunirine, a CD123-targeting ADC that is in Phase II clinical trial for treating acute myeloid leukemia and blastic plasmacytoid dendritic cell neoplasm. Its preclinical programs include IMGC936, an ADC in co-development with MacroGenics, Inc.; and IMGN151, an anti-FRa product candidate. The company has collaborations with Roche; Amgen/Oxford BioTherapeutics; Bayer HealthCare AG; Eli Lilly and Company; Novartis Institutes for BioMedical Research, Inc.; CytomX Therapeutics, Inc.; Fusion Pharmaceuticals Inc.; Debiopharm International SA; and MacroGenics, Inc. ImmunoGen, Inc. was founded in 1980 and is headquartered in Waltham, Massachusetts.
NASDAQ ended the session with ImmunoGen dropping 13.63% to $14.73 on Monday while NASDAQ jumped 0.61% to $13,994.40.
Earnings Per Share
As for profitability, ImmunoGen has a trailing twelve months EPS of $-0.93.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -111.95%.
Sales Growth
ImmunoGen’s sales growth is 241.4% for the present quarter and 339.8% for the next.
Volatility
ImmunoGen’s last week, last month’s, and last quarter’s current intraday variation average was a negative 1.14%, a negative 0.39%, and a positive 2.45%.
ImmunoGen’s highest amplitude of average volatility was 3.79% (last week), 2.67% (last month), and 2.45% (last quarter).
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter and the next is 41.7% and 64.5%, respectively.
Revenue Growth
Year-on-year quarterly revenue growth grew by 31%, now sitting on 120.57M for the twelve trailing months.
More news about ImmunoGen.
3. Aspen Group (ASPU) – -8.82%
Aspen Group, Inc., an education technology company, provides online higher education services in the United States. The company offers baccalaureate, master's, and doctoral degree programs in nursing and health sciences, business and technology, arts and sciences, and education fields through Aspen University and United States University. As of April 30, 2022, it had 13,334 degree-seeking students enrolled. Aspen Group, Inc. was founded in 1987 and is based in New York, New York.
NASDAQ ended the session with Aspen Group dropping 8.82% to $0.16 on Monday, after two successive sessions in a row of losses. NASDAQ jumped 0.61% to $13,994.40, after four successive sessions in a row of losses, on what was a somewhat bullish trend trading session today.
Earnings Per Share
As for profitability, Aspen Group has a trailing twelve months EPS of $-0.36.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -24.26%.
Volume
Today’s last reported volume for Aspen Group is 46955 which is 19.96% below its average volume of 58668.
Sales Growth
Aspen Group’s sales growth is negative 24% for the present quarter and negative 29.3% for the next.
Volatility
Aspen Group’s last week, last month’s, and last quarter’s current intraday variation average was 0.04%, 1.66%, and 5.78%.
Aspen Group’s highest amplitude of average volatility was 3.64% (last week), 5.48% (last month), and 5.78% (last quarter).
More news about Aspen Group.
4. BeiGene (BGNE) – -8.08%
BeiGene, Ltd., a biotechnology company, develops and commercializes oncology medicines worldwide. Its products include BRUKINSA to treat various blood cancers; Tislelizumab to treat various solid tumor and blood cancers; REVLIMID to treat multiple myeloma; VIDAZA to treat myelodysplastic syndromes, chronic myelomonocyte leukemia, and acute myeloid leukemia; XGEVA to treat bone metastases from solid tumors and multiple myeloma, as well as giant cell tumor of bone; BLINCYTO to treat acute lymphoblastic leukemia; KYPROLIS to treat R/R multiple myeloma; SYLVANT to treat idiopathic multicentric castleman disease; QARZIBA to treat neuroblastoma; Pamiparib for the treatment of various solid tumor malignancies; and Pobevcy to treat metastatic colorectal cancer, liver cancer, and non-small cell lung cancer (NSCLC). The company is also developing Zanubrutinib to treat B-cell malignancies; Tislelizumab, an anti-PD-1 antibody to treat solid and hematological cancers; Ociperlimab for treating solid tumors, cervical cancer, and NSCLC; Surzebiclimab, BGB-A445, BGB-15025, Lifirafenib, BGB-24714, and BGB-B167 to treat solid tumors; BGB-10188 for treating solid tumors, B-cell lymphoid malignancies, and B-cell malignancies; BGB-11417 to treat R/R chronic lymphocytic leukemia/ small lymphocytic lymphoma, R/R mantle cell lymphoma, Mature B-cell malignancies, Myeloid malignancies, and R/R multiple myeloma; BGB-16673 for B-cell malignancies; and BGB-23339 for Inflammation and immunology. The company has collaborations with Shoreline Biosciences, Inc., Amgen Inc., Novartis AG, Bristol Myers Squibb company, Shandong Luye Pharmaceutical Co., Ltd., Nanjing Leads Biolabs, Inc., EUSA Pharma, Assembly Biosciences, Inc., Bio-Thera Solutions, Ltd., and Enlivex Therapeutics Ltd. BeiGene, Ltd. was incorporated in 2010 and is based in Grand Cayman, the Cayman Islands.
NASDAQ ended the session with BeiGene falling 8.08% to $185.93 on Monday while NASDAQ jumped 0.61% to $13,994.40.
Earnings Per Share
As for profitability, BeiGene has a trailing twelve months EPS of $-18.4.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -38.18%.
Yearly Top and Bottom Value
BeiGene’s stock is valued at $185.93 at 17:32 EST, way under its 52-week high of $280.62 and way higher than its 52-week low of $124.46.
More news about BeiGene.
5. Redfin (RDFN) – -7.81%
Redfin Corporation operates as a residential real estate brokerage company in the United States and Canada. The company operates an online real estate marketplace and provides real estate services, including assisting individuals in the purchase or sell of home. It also provides title and settlement services; and originates and sells mortgages. The company was formerly known as Appliance Computing Inc. and changed its name to Redfin Corporation in May 2006. Redfin Corporation was incorporated in 2002 and is headquartered in Seattle, Washington.
NASDAQ ended the session with Redfin falling 7.81% to $10.00 on Monday while NASDAQ rose 0.61% to $13,994.40.
Earnings Per Share
As for profitability, Redfin has a trailing twelve months EPS of $-2.89.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -173.25%.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Redfin’s stock is considered to be overbought (>=80).
Moving Average
Redfin’s value is way under its 50-day moving average of $12.16 and way above its 200-day moving average of $8.03.
More news about Redfin.
6. Neonode (NEON) – -7.76%
Neonode Inc., together with its subsidiaries, develops optical sensing solutions for contactless touch, touch, gesture sensing, and in-cabin monitoring in the United States, Japan, South Korea, China, and internationally. The company also licenses its technology to original equipment manufacturers (OEMs) and Tier 1 suppliers. In addition, it provides embedded sensors to OEMs, original design manufacturers, and Tier 1 suppliers. Further, the company sells Neonode branded sensor products, such as AirBar products through distributors. Additionally, it provides engineering consulting services. Neonode Inc. was incorporated in 1997 and is headquartered in Stockholm, Sweden.
NASDAQ ended the session with Neonode sliding 7.76% to $2.14 on Monday, after four sequential sessions in a row of losses. NASDAQ rose 0.61% to $13,994.40, after four consecutive sessions in a row of losses, on what was a somewhat positive trend exchanging session today.
Earnings Per Share
As for profitability, Neonode has a trailing twelve months EPS of $-0.34.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -23.75%.
Revenue Growth
Year-on-year quarterly revenue growth declined by 4.9%, now sitting on 5.61M for the twelve trailing months.
Sales Growth
Neonode’s sales growth is 57.9% for the ongoing quarter and 64.5% for the next.
Moving Average
Neonode’s worth is way under its 50-day moving average of $6.42 and way under its 200-day moving average of $6.59.
Volume
Today’s last reported volume for Neonode is 510086 which is 263.99% above its average volume of 140135.
More news about Neonode.
7. NN (NNBR) – -7.72%
NN, Inc., a diversified industrial company, designs, manufactures, and sells high-precision components and assemblies primarily for the electrical, automotive, general industrial, aerospace and defense, and medical markets. It operates through Mobile Solutions and Power Solutions segments. The Mobile Solutions segment manufactures and sells system critical components for fuel systems, engines and transmissions, power steering systems, and electromechanical motors for general industrial and automotive end markets. The Power Solutions segment designs, manufactures, and sells a range of high-precision metal and plastic components, assemblies, and finished devices used in applications ranging from power control to flight control and for military devices. Its products include electrical contacts, connectors, contact assemblies, and precision stampings for the electrical end market; and high precision products for the aerospace and defense end markets. This segment also produces various tools and instruments for the orthopaedics and medical/surgical end markets. The company sells its products worldwide primarily to manufacturers directly. NN, Inc. was founded in 1980 and is headquartered in Charlotte, North Carolina.
NASDAQ ended the session with NN dropping 7.72% to $2.75 on Monday while NASDAQ rose 0.61% to $13,994.40.
Earnings Per Share
As for profitability, NN has a trailing twelve months EPS of $-1.03.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -15.35%.
Yearly Top and Bottom Value
NN’s stock is valued at $2.75 at 17:32 EST, way below its 52-week high of $3.25 and way higher than its 52-week low of $0.97.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter is a negative 33.3% and positive 108.3% for the next.
Sales Growth
NN’s sales growth is 6% for the present quarter and 8.5% for the next.
Volume
Today’s last reported volume for NN is 200763 which is 27.47% below its average volume of 276827.
More news about NN.
8. SmileDirectClub (SDC) – -7.62%
SmileDirectClub, Inc., an oral care company, offers clear aligner therapy treatment. The company manages the end-to-end process, which include marketing, aligner manufacturing, fulfillment, treatment by a customer's dentist or orthodontist, and facilitating remote clinical monitoring through a network of orthodontists and general dentists through its proprietary teledentistry platform, SmileCheck in the United States, Puerto Rico, Canada, Australia, the United Kingdom, New Zealand, Ireland, Hong Kong, Germany, Singapore, France, Spain, and Austria. It also offers aligners, impression and whitening kits, whitening gels, and retainers; and toothbrushes, toothpastes, water flossers, SmileSpa, and various ancillary oral care products. The company was founded in 2014 and is headquartered in Nashville, Tennessee.
NASDAQ ended the session with SmileDirectClub falling 7.62% to $0.84 on Monday, after two successive sessions in a row of gains. NASDAQ jumped 0.61% to $13,994.40, after four sequential sessions in a row of losses, on what was a somewhat bullish trend exchanging session today.
Earnings Per Share
As for profitability, SmileDirectClub has a trailing twelve months EPS of $-2.628.
Volatility
SmileDirectClub’s last week, last month’s, and last quarter’s current intraday variation average was 1.52%, 2.80%, and 5.95%.
SmileDirectClub’s highest amplitude of average volatility was 14.16% (last week), 9.48% (last month), and 5.95% (last quarter).
Earnings Before Interest, Taxes, Depreciation, and Amortization
SmileDirectClub’s EBITDA is -19.81.
Yearly Top and Bottom Value
SmileDirectClub’s stock is valued at $0.84 at 17:32 EST, way under its 52-week high of $2.26 and way above its 52-week low of $0.32.
Volume
Today’s last reported volume for SmileDirectClub is 1823280 which is 12.42% below its average volume of 2081900.
More news about SmileDirectClub.
9. Nikola (NKLA) – -7.61%
Nikola Corporation operates as a technology innovator and integrator that develops energy and transportation solutions. It operates through two business units, Truck and Energy. The Truck business unit develops and commercializes battery electric vehicles (BEV) and hydrogen fuel cell electric vehicles (FCEV) to the trucking sector. The Energy business unit develops and constructs a network of hydrogen fueling stations; and offers BEV charging solutions for its FCEV and BEV customers, as well as other third-party customers. The company also assembles, integrates, and commissions its vehicles in collaboration with its business partners and suppliers. Nikola Corporation founded in 2015 and is headquartered in Phoenix, Arizona.
NASDAQ ended the session with Nikola falling 7.61% to $2.31 on Monday, following the last session’s downward trend. NASDAQ rose 0.61% to $13,994.40, after four consecutive sessions in a row of losses, on what was a somewhat positive trend trading session today.
Earnings Per Share
As for profitability, Nikola has a trailing twelve months EPS of $-1.4.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -137.05%.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Nikola’s stock is considered to be overbought (>=80).
Moving Average
Nikola’s worth is way higher than its 50-day moving average of $1.31 and way above its 200-day moving average of $1.92.
Yearly Top and Bottom Value
Nikola’s stock is valued at $2.31 at 17:32 EST, way below its 52-week high of $8.97 and way higher than its 52-week low of $0.52.
More news about Nikola.
10. FibroGen (FGEN) – -7.59%
FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. Its lead product candidates are Pamrevlumab, a human monoclonal antibody targeting connective tissue growth factor that is in Phase III clinical development for the treatment of idiopathic pulmonary fibrosis, pancreatic cancer, and Duchenne muscular dystrophy; and Roxadustat, an oral small molecule inhibitor of hypoxia-inducible factor prolyl hydroxylase activity, which has completed Phase III clinical development for the treatment of anemia in chronic kidney disease in China, Europe, Japan, and other countries, as well as in Phase III clinical development for anemia related with myelodysplastic syndromes. The company has collaboration agreements with Astellas Pharma Inc. and AstraZeneca AB. FibroGen, Inc. was incorporated in 1993 and is headquartered in San Francisco, California.
NASDAQ ended the session with FibroGen dropping 7.59% to $1.77 on Monday while NASDAQ rose 0.61% to $13,994.40.
Earnings Per Share
As for profitability, FibroGen has a trailing twelve months EPS of $-2.84.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -411.93%.
Volatility
FibroGen’s last week, last month’s, and last quarter’s current intraday variation average was a negative 1.93%, a negative 1.78%, and a positive 2.93%.
FibroGen’s highest amplitude of average volatility was 2.73% (last week), 3.67% (last month), and 2.93% (last quarter).
Earnings Before Interest, Taxes, Depreciation, and Amortization
FibroGen’s EBITDA is -19.6.
More news about FibroGen.
Stay up to date with our winners and losers daily report
